3-((3,5-Dimethoxyphenyl)amino)benzo[d]isothiazole 1,1-dioxide

ID: ALA4877533

Chembl Id: CHEMBL4877533

PubChem CID: 164628923

Max Phase: Preclinical

Molecular Formula: C15H14N2O4S

Molecular Weight: 318.35

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(NC2=NS(=O)(=O)c3ccccc32)cc(OC)c1

Standard InChI:  InChI=1S/C15H14N2O4S/c1-20-11-7-10(8-12(9-11)21-2)16-15-13-5-3-4-6-14(13)22(18,19)17-15/h3-9H,1-2H3,(H,16,17)

Standard InChI Key:  FDUBYIQRQKHJCY-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4877533

    ---

Associated Targets(Human)

EPAS1 Tclin Endothelial PAS domain-containing protein 1 (498 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ARNT Tbio Aryl hydrocarbon receptor nuclear translocator/Endothelial PAS domain-containing protein 1 (77 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 318.35Molecular Weight (Monoisotopic): 318.0674AlogP: 2.26#Rotatable Bonds: 3
Polar Surface Area: 76.99Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 1.94CX LogD: 1.94
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.94Np Likeness Score: -1.47

References

1. Yu Y, Yu Q, Liu S, Wu C, Zhang X..  (2021)  Insight into the binding mode of HIF-2 agonists through molecular dynamic simulations and biological validation.,  211  [PMID:33189439] [10.1016/j.ejmech.2020.112999]
2. Yu Y, Yang F, Yu Q, Liu S, Wu C, Su K, Yang L, Bao X, Li Z, Li X, Zhang X..  (2021)  Discovery of a Potent and Orally Bioavailable Hypoxia-Inducible Factor 2α (HIF-2α) Agonist and Its Synergistic Therapy with Prolyl Hydroxylase Inhibitors for the Treatment of Renal Anemia.,  64  (23.0): [PMID:34709043] [10.1021/acs.jmedchem.1c01479]
3. Song W, Zhuang J, Zhang N, Ren X, Xu W, Guo M, Diao X, Liu C, Jin J, Wu D, Zhang Y..  (2023)  SAR study of 1,2-benzisothiazole dioxide compounds that agonize HIF-2 stabilization and EPO production.,  77  [PMID:36521398] [10.1016/j.bmc.2022.117041]

Source